Form 4: TransDigm Director Graff Receives 518 Stock Options

TransDigm Group Inc. director Michael Graff was granted 518 stock options with an exercise price of $1,291.97, exercisable over five years starting September 30, 2026, contingent on performance targets.

Summary

• Michael Graff, a director of TransDigm Group INC (TDG), was granted 518 stock options.
• The options have an exercise price of $1,291.97 per share.
• The transaction date for the grant was November 4, 2025.
• These options expire on November 4, 2035.
• The options become exercisable at 20% per year over five years, beginning September 30, 2026.
• Exercisability is subject to the achievement of annual operating performance targets in each year.
• Following this transaction, Michael Graff directly beneficially owns 518 derivative securities (stock options).

Sentiment

Score: 6

Explanation: The filing reports a standard grant of performance-based stock options to a director, which is a neutral event in terms of immediate company performance but can be seen as a positive for corporate governance by aligning director incentives with long-term company success.

Positives

• The grant of stock options to Director Michael Graff aligns his interests with long-term shareholder value, as exercisability is tied to company performance.
• The options have a 10-year expiration date, providing a long-term incentive horizon.

Risks

• The exercisability of the stock options is contingent upon the achievement of annual operating performance targets, meaning the options may not fully vest if targets are not met.

Future Outlook

The stock options granted to Director Michael Graff are exercisable over five years beginning September 30, 2026, contingent on the achievement of annual operating performance targets, indicating a future focus on performance-based incentives.

Industry Context

The grant of performance-based stock options is a common practice in the aerospace and defense industry, where TransDigm Group operates, to incentivize executive and director performance and align their interests with long-term shareholder value.

Comparison to Industry Standards

• The use of performance-based stock options for director compensation is a standard practice across many industries, including aerospace and defense, to link executive and director incentives directly to company operational and financial achievements.
• While specific comparable companies or projects are not detailed in the filing, this type of equity grant structure is consistent with compensation strategies observed at peers like Raytheon Technologies (RTX), Lockheed Martin (LMT), or Boeing (BA), which often incorporate long-term incentive plans tied to metrics such as revenue growth, EPS, or total shareholder return.

Corporate Governance

Related Party Transactions

• The grant of 518 stock options to Michael Graff, a director of TransDigm Group INC, constitutes a related party transaction between the company and its director.

Stakeholder Impact

• Shareholders: The performance-based nature of the options aligns the director's incentives with shareholder interests, potentially leading to better long-term company performance.
• Management/Directors: Michael Graff receives a long-term equity incentive, contingent on achieving performance targets.

Next Steps

• The stock options will become exercisable at 20% per year over five years, starting September 30, 2026.
• Annual operating performance targets must be achieved for the options to vest each year.

Key Dates

Recommendation

This Form 4 filing details a routine insider transaction involving a director's stock option grant. It does not provide new financial performance data or strategic shifts that would warrant a change in investment recommendation. The performance-based nature of the options is a standard governance practice. Therefore, a "hold" recommendation is appropriate as the filing itself does not present a compelling reason to buy or sell, and existing investment theses would remain unchanged.

Keywords

TransDigm Group, TDG, Michael Graff, Stock Options, Director Compensation, SEC Form 4, Insider Transaction, Equity Grant, Performance-Based Compensation